These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 17875680

  • 1. TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling.
    Woodfield GW, Horan AD, Chen Y, Weigel RJ.
    Cancer Res; 2007 Sep 15; 67(18):8439-43. PubMed ID: 17875680
    [Abstract] [Full Text] [Related]

  • 2. Molecular identification of ERalpha-positive breast cancer cells by the expression profile of an intrinsic set of estrogen regulated genes.
    Weisz A, Basile W, Scafoglio C, Altucci L, Bresciani F, Facchiano A, Sismondi P, Cicatiello L, De Bortoli M.
    J Cell Physiol; 2004 Sep 15; 200(3):440-50. PubMed ID: 15254972
    [Abstract] [Full Text] [Related]

  • 3. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.
    Zhao C, Matthews J, Tujague M, Wan J, Ström A, Toresson G, Lam EW, Cheng G, Gustafsson JA, Dahlman-Wright K.
    Cancer Res; 2007 Apr 15; 67(8):3955-62. PubMed ID: 17440111
    [Abstract] [Full Text] [Related]

  • 4. Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer.
    Lin Z, Reierstad S, Huang CC, Bulun SE.
    Cancer Res; 2007 May 15; 67(10):5017-24. PubMed ID: 17510434
    [Abstract] [Full Text] [Related]

  • 5. Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach.
    Tozlu S, Girault I, Vacher S, Vendrell J, Andrieu C, Spyratos F, Cohen P, Lidereau R, Bieche I.
    Endocr Relat Cancer; 2006 Dec 15; 13(4):1109-20. PubMed ID: 17158757
    [Abstract] [Full Text] [Related]

  • 6. Tamoxifen induces the expression of maspin through estrogen receptor-alpha.
    Liu Z, Shi HY, Nawaz Z, Zhang M.
    Cancer Lett; 2004 Jun 08; 209(1):55-65. PubMed ID: 15145521
    [Abstract] [Full Text] [Related]

  • 7. Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins.
    Stoner M, Wormke M, Saville B, Samudio I, Qin C, Abdelrahim M, Safe S.
    Oncogene; 2004 Feb 05; 23(5):1052-63. PubMed ID: 14647449
    [Abstract] [Full Text] [Related]

  • 8. Eliminating epigenetic barriers induces transient hormone-regulated gene expression in estrogen receptor negative breast cancer cells.
    Fleury L, Gerus M, Lavigne AC, Richard-Foy H, Bystricky K.
    Oncogene; 2008 Jul 03; 27(29):4075-85. PubMed ID: 18317449
    [Abstract] [Full Text] [Related]

  • 9. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1.
    Maor S, Mayer D, Yarden RI, Lee AV, Sarfstein R, Werner H, Papa MZ.
    J Endocrinol; 2006 Dec 03; 191(3):605-12. PubMed ID: 17170218
    [Abstract] [Full Text] [Related]

  • 10. MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERalpha) in regulation of the MUC1 gene expression.
    Zaretsky JZ, Barnea I, Aylon Y, Gorivodsky M, Wreschner DH, Keydar I.
    Mol Cancer; 2006 Nov 05; 5():57. PubMed ID: 17083744
    [Abstract] [Full Text] [Related]

  • 11. Selenium disrupts estrogen signaling by altering estrogen receptor expression and ligand binding in human breast cancer cells.
    Lee SO, Nadiminty N, Wu XX, Lou W, Dong Y, Ip C, Onate SA, Gao AC.
    Cancer Res; 2005 Apr 15; 65(8):3487-92. PubMed ID: 15833885
    [Abstract] [Full Text] [Related]

  • 12. Estrogen regulation and physiopathologic significance of alternative promoters in breast cancer.
    Dutertre M, Gratadou L, Dardenne E, Germann S, Samaan S, Lidereau R, Driouch K, de la Grange P, Auboeuf D.
    Cancer Res; 2010 May 01; 70(9):3760-70. PubMed ID: 20406972
    [Abstract] [Full Text] [Related]

  • 13. Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity.
    Deblois G, Hall JA, Perry MC, Laganière J, Ghahremani M, Park M, Hallett M, Giguère V.
    Cancer Res; 2009 Aug 01; 69(15):6149-57. PubMed ID: 19622763
    [Abstract] [Full Text] [Related]

  • 14. Selective hormone-dependent repression of estrogen receptor beta by a p38-activated ErbB2/ErbB3 pathway.
    St-Laurent V, Sanchez M, Charbonneau C, Tremblay A.
    J Steroid Biochem Mol Biol; 2005 Feb 01; 94(1-3):23-37. PubMed ID: 15862947
    [Abstract] [Full Text] [Related]

  • 15. Oxytocin modulates estrogen receptor alpha expression and function in MCF7 human breast cancer cells.
    Cassoni P, Catalano MG, Sapino A, Marrocco T, Fazzari A, Bussolati G, Fortunati N.
    Int J Oncol; 2002 Aug 01; 21(2):375-8. PubMed ID: 12118334
    [Abstract] [Full Text] [Related]

  • 16. Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines.
    Leivonen SK, Mäkelä R, Ostling P, Kohonen P, Haapa-Paananen S, Kleivi K, Enerly E, Aakula A, Hellström K, Sahlberg N, Kristensen VN, Børresen-Dale AL, Saviranta P, Perälä M, Kallioniemi O.
    Oncogene; 2009 Nov 05; 28(44):3926-36. PubMed ID: 19684618
    [Abstract] [Full Text] [Related]

  • 17. Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway.
    Sauvé K, Lepage J, Sanchez M, Heveker N, Tremblay A.
    Cancer Res; 2009 Jul 15; 69(14):5793-800. PubMed ID: 19584281
    [Abstract] [Full Text] [Related]

  • 18. Reactive oxygen species induce phosphorylation of serine 118 and 167 on estrogen receptor alpha.
    Weitsman GE, Weebadda W, Ung K, Murphy LC.
    Breast Cancer Res Treat; 2009 Nov 15; 118(2):269-79. PubMed ID: 18941890
    [Abstract] [Full Text] [Related]

  • 19. Activation of an estrogen/estrogen receptor signaling by BIG3 through its inhibitory effect on nuclear transport of PHB2/REA in breast cancer.
    Kim JW, Akiyama M, Park JH, Lin ML, Shimo A, Ueki T, Daigo Y, Tsunoda T, Nishidate T, Nakamura Y, Katagiri T.
    Cancer Sci; 2009 Aug 15; 100(8):1468-78. PubMed ID: 19496786
    [Abstract] [Full Text] [Related]

  • 20. High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors.
    Marot D, Bieche I, Aumas C, Esselin S, Bouquet C, Vacher S, Lazennec G, Perricaudet M, Kuttenn F, Lidereau R, de Roux N.
    Endocr Relat Cancer; 2007 Sep 15; 14(3):691-702. PubMed ID: 17914099
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.